Overview

Pharmacokinetic Study of Single and Multiple Intravenous Administration of Nalbuphine Hydrochloride Injection in Healthy Chinese Volunteers

Status:
COMPLETED

Trial end date:
2024-01-18

Target enrollment:

Participant gender:

Summary

ObjectiveTo evaluate the pharmacokinetic characteristics and safety of single and multiple intravenous injections of nalbuphine hydrochloride injection in healthy subjects.

Phase:

PHASE1

Details

Lead Sponsor:

Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd